• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    From Lab Rats And Eyeballs To Cannabis: Scarlet Express CEO Discusses Closed-Loop Delivery, How To 'Survive In Chaos'

    7/4/24 9:43:18 AM ET
    $CAH
    $MCK
    Other Pharmaceuticals
    Health Care
    Other Pharmaceuticals
    Health Care
    Get the next $CAH alert in real time by email

    First, Claudia Post oversaw the safe delivery of eyeballs, kidneys and other organs. Today? Her specialty is cannabis.

    Most recently, she launched Scarlet Express with financial backing from Ben Sopranzetti, vice chair of the Department of Finance and Economics at Rutgers Business School.

    The Philadelphia-based startup is a state-approved, closed-loop delivery organization providing discreet, secure and expert cannabis supply chain management nationwide.

    And Post is the perfect person for this type of venture. A serial entrepreneur, Post launched MOST Consulting Group, a one-stop shop for cannabis marketing and advertising, and founded Diamond Transportation Group, a same-day, time-critical delivery service, in the early 1990s.

    See Also: $2.9B European Cannabis Market: A Strategic Blueprint For Cross-Border Transportation Logistics

    Post went on to open 12 warehouses along the East Coast offering trucking, pick-pack-ship, logistics and other services. And anyone who follows the inner workings of the nascent cannabis industry knows that transporting marijuana across state lines is fraught with challenges.

    Despite President Joe Biden’s proposal to reclassify marijuana from its position as a Schedule I drug to a less dangerous Schedule III, a mishmash of federal and state laws, combined with varying enforcement policies, makes interstate transport federally illegal and a headache for businesses.

    Benzinga spoke with Post at the recent Benzinga Cannabis Market Spotlight event. Here’s what she had to say about the dire need for efficient cannabis transportation:

    BZ: How did you wind up in cannabis?

    Post: I’ve been in the cannabis industry for 14 years. I opened a marketing communications agency called MOST Consulting. We do design, content, strategy — anything in the communication space. Need a truck wrap? We’ll do a truck wrap.

    Also, my son is a very famous glassblower. He makes pipes, bongs and collectibles. His nom de plume is Snick Barnes. He’s in Philly, but he’s known all over the world. And he said, “Ma, you’ve got to get into cannabis. It’s going to blow up.” I said, “Okay.” And he was absolutely right.

    BZ: He was ahead of the curve.

    I’d like to think our little family is. Then I started going to things like Champs Trade Shows. And when medical cannabis started emerging, I worked with the then-governor of Pennsylvania to bring medical marijuana to the state.

    But before that, I had a rather large, multi-state transportation company called Diamond. I had 12 locations up and down the East Coast.

    BZ: What were you transporting?

    We did same-date, time-critical delivery. Some of my clients were large pharmaceutical distributors like Cardinal Health (NYSE:CAH) and McKesson Corp (NYSE:MCK). So, I understand the compliance and the necessity for handling schedule one narcotics, etcetera. We would also move lab rats that were [valued at] $20,000. We would do all kinds of deliveries like body parts, eyeballs, kidneys…

    BZ: Organ transplants?

    Yes.

    BZ: How much ice do you need to transport organs? A lot, right?

    Yes. And it’s a very specialized pickup and delivery. Let’s say the eyeballs were in California. We would get an alert and have our affiliate in Los Angeles pick up the part, and put it on the plane.

    All of my drivers were TSA-certified, which means they’re excruciatingly detailed. We put freight in the belly of the plane. And that was tracked through to the operatory and done correctly within the compliance of the TSA.

    So, the magnitude of my understanding of being compliant is very high. I would hazard to say, I don’t know anybody in the cannabis industry who has the background that I do — in transportation, anyway.

    BZ: Are your hopes high for later this year that cannabis will be rescheduled?

    I don’t think it’ll happen this year. But I have hopes. Hope isn’t always a strategy, but I do have hopes that it will happen. And we should have de-scheduling, not rescheduling. De-scheduling means it’s just like we could go buy beer. Rescheduling means it goes into another category that is monitored, tracked, and all that other s—. Sorry, I’m very direct.

    BZ: What is the focus of Scarlet Express?

    We pick it up at a “grow;” take it to a dispensary; pick it up at the manufacturer; pick it up at a dispensary and take it to you. I’m a startup, and I have letters of intent. The difference between me and others is many years of experience and understanding of what you need to be compliant and mitigate risk.

    BZ: What sort of challenges do you foresee in cannabis transportation?

    You have a bunch of legislators writing policy, and not understanding anything about delivery. That is what often happens.

    Why do things in isolation, when you have a world of people you could call on? Pennsylvania held a symposium where they called in a variety of people to testify, including someone from Massachusetts, which has one of the most onerous [cannabis transportation] policies. Ask experts. Ask somebody who knows what delivery is about.

    BZ: How did New Jersey roll out its cannabis program?

    It had its problems, just like every other state. It was slow. I testified before the Cannabis Regulatory Commission (CRC). This lovely man rented a space, paying something like $18,000 a month, and the CRC is sitting on it for two years. They haven’t actualized his license. Why? My heart bleeds. I ache for people who are being taken advantage of. It’s just terrible.

    BZ: What do you want potential clients/investors to know about Scarlet Express?

    If someone were to come to me and say, “I’ve got $75 million, and I want to have the largest national delivery service,” I would say, because of my background and years of experience in transportation, “I’m a sure bet.” I already built a large company in transportation. My network is very deep across the country. I also understand high-value, compliant delivery, as well as the insurance component and how to scale anywhere.

    I’m a problem solver. The basic thing about somebody in logistics, is you have to be able to survive in chaos. And you have to be able to make decisions quickly, turn on a dime. If there’s ever an issue with a driver, we have to send somebody to relay [cargo] wherever it has to go. You have to be able to think quickly.

    BZ: With your expertise, you could handle logistics for anything. Why cannabis?

    People always ask me, “How do I get in the industry?” Take a skill set. I know delivery and transportation inside and out. And it just seems natural to me because I own the marketing agency and they sort of dovetail together.

    Now Read:

    • Can Cannabis ‘Bring Retail Back To Life'? Verano, Curaleaf, NewLake Capital Bet Big On Local New Jersey Market

    Photo: Benzinga

    Get the next $CAH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CAH
    $MCK

    CompanyDatePrice TargetRatingAnalyst
    Cardinal Health Inc.
    $CAH
    6/3/2025$179.00Equal Weight → Overweight
    Wells Fargo
    Cardinal Health Inc.
    $CAH
    2/5/2025$140.00 → $150.00Hold → Buy
    Jefferies
    Cardinal Health Inc.
    $CAH
    1/8/2025$130.00 → $144.00Hold → Buy
    TD Cowen
    Cardinal Health Inc.
    $CAH
    1/7/2025$140.00In-line → Outperform
    Evercore ISI
    Cardinal Health Inc.
    $CAH
    1/6/2025$132.00 → $145.00Neutral → Buy
    BofA Securities
    Cardinal Health Inc.
    $CAH
    12/13/2024$101.00 → $127.00Underweight → Equal Weight
    Wells Fargo
    McKesson Corporation
    $MCK
    12/4/2024$630.00Neutral
    Mizuho
    Cardinal Health Inc.
    $CAH
    12/4/2024$139.00Outperform
    Mizuho
    More analyst ratings

    $CAH
    $MCK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cardinal Health upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded Cardinal Health from Equal Weight to Overweight and set a new price target of $179.00

      6/3/25 7:24:57 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health upgraded by Jefferies with a new price target

      Jefferies upgraded Cardinal Health from Hold to Buy and set a new price target of $150.00 from $140.00 previously

      2/5/25 7:09:45 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health upgraded by TD Cowen with a new price target

      TD Cowen upgraded Cardinal Health from Hold to Buy and set a new price target of $144.00 from $130.00 previously

      1/8/25 7:36:58 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    $MCK
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • McKesson Corporation Announces First Quarter Fiscal 2026 Earnings Release Date

      McKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson's Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to he

      6/26/25 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • After Major Oncology Conference, All Eyes Turn to Industry Innovation

      USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- After the close of the world's largest cancer conference (the 2025 American Society of Clinical Oncology annual meeting), doctors, scientists, and researchers are optimistic, especially in the fields of immunotherapy, Car T-cell therapy, liquid biopsies, breast cancer, AI, and even exercise. However, with reports coming out that the current US administration could drastically reduce funding of the National Cancer Institute (NCI) by nearly 40%, the market is looking towards the private sector to pick up the slack and continue to make advancements in cancer treatment. For inv

      6/12/25 9:00:00 AM ET
      $CAH
      $CTOR
      $CTXR
      $ONCY
      Other Pharmaceuticals
      Health Care
      Biotechnology: Pharmaceutical Preparations
    • NYSE Content Advisory: Pre-Market update + Voyager, Ategrity pop double digits in debuts

      NEW YORK, June 12, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Kristen Scholer delivers the pre-market update on June 12th Stocks are down fractionally this morning after the S&P 500 ended a three-day win streak yesterday. The major index is about 2% from its record.Amid the market momentum, Voyager Technologies (NYSE:VOYG) and Ategrity (NYSE: ASIC) popped double digits in their debuts yesterday. Voyager is a $3.1 billion space and defense company. Ategrity is an insurer valued at about $1.2 billio

      6/12/25 8:55:00 AM ET
      $CAH
      $ICE
      Other Pharmaceuticals
      Health Care
      Investment Bankers/Brokers/Service
      Finance

    $CAH
    $MCK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Legal/Compliance Officer Mayer Jessica L covered exercise/tax liability with 5,176 shares, decreasing direct ownership by 9% to 55,110 units (SEC Form 4)

      4 - CARDINAL HEALTH INC (0000721371) (Issuer)

      6/30/25 4:18:28 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • CEO, GMPD Segment Mason Stephen M covered exercise/tax liability with 5,694 shares, decreasing direct ownership by 14% to 34,977 units (SEC Form 4)

      4 - CARDINAL HEALTH INC (0000721371) (Issuer)

      6/30/25 4:17:48 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Chief Executive Officer Hollar Jason M. covered exercise/tax liability with 5,821 shares, decreasing direct ownership by 3% to 191,815 units (SEC Form 4)

      4 - CARDINAL HEALTH INC (0000721371) (Issuer)

      6/30/25 4:16:56 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    $MCK
    SEC Filings

    See more
    • SEC Form DEFA14A filed by McKesson Corporation

      DEFA14A - MCKESSON CORP (0000927653) (Filer)

      6/20/25 4:26:12 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form DEF 14A filed by McKesson Corporation

      DEF 14A - MCKESSON CORP (0000927653) (Filer)

      6/20/25 4:19:35 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form 11-K filed by Cardinal Health Inc.

      11-K - CARDINAL HEALTH INC (0000721371) (Filer)

      6/20/25 8:32:15 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    $MCK
    Leadership Updates

    Live Leadership Updates

    See more
    • After Major Oncology Conference, All Eyes Turn to Industry Innovation

      USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- After the close of the world's largest cancer conference (the 2025 American Society of Clinical Oncology annual meeting), doctors, scientists, and researchers are optimistic, especially in the fields of immunotherapy, Car T-cell therapy, liquid biopsies, breast cancer, AI, and even exercise. However, with reports coming out that the current US administration could drastically reduce funding of the National Cancer Institute (NCI) by nearly 40%, the market is looking towards the private sector to pick up the slack and continue to make advancements in cancer treatment. For inv

      6/12/25 9:00:00 AM ET
      $CAH
      $CTOR
      $CTXR
      $ONCY
      Other Pharmaceuticals
      Health Care
      Biotechnology: Pharmaceutical Preparations
    • Carlisle Companies Announces Leadership Appointments

      Carlisle Companies Incorporated (NYSE:CSL) today announced the appointment of Christopher B. Gaskill as Vice President & General Counsel for the Company. In conjunction with this appointment, Scott C. Selbach will transition to a new role as Executive Vice President, Government Relations for the Company. Mr. Selbach will also remain Secretary of the Company. Both Mr. Gaskill and Mr. Selbach will report to Chris Koch, Carlisle's Chair, President & Chief Executive Officer. Prior to joining Carlisle, Mr. Gaskill served as Executive Vice President, Chief Legal Officer, and Secretary at Summit Materials, Inc. (NYSE:SUM), where he was responsible for the company's global legal functions and ensu

      5/16/25 4:05:00 PM ET
      $CAH
      $CSL
      $SUM
      $WU
      Other Pharmaceuticals
      Health Care
      Specialty Chemicals
      Industrials
    • Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors

      DUBLIN, Ohio, March 10, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Healthcare Corp., and Sudhakar Ramakrishna, President and Chief Executive Officer of SolarWinds Corporation, as independent directors, effective March 7, 2025. With more than 20 years of leadership experience, including serving as CEO for two publicly traded companies, Mr. Musslewhite brings to the board unique expertise in advanced analytics, data, and technology across the healthcare e

      3/10/25 6:45:00 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    $MCK
    Financials

    Live finance-specific insights

    See more
    • McKesson Corporation Announces First Quarter Fiscal 2026 Earnings Release Date

      McKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. The live and archived audio webcast will be available on McKesson's Investor Relations website. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products and services to he

      6/26/25 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • McKesson Corporation Completes Acquisition of Core Ventures

      Strengthens Community-Based Oncology Care with Florida Cancer Specialists & Research Institute Core Ventures McKesson Corporation (NYSE:MCK) announced today that it has completed the acquisition of a controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures), a business and administrative services organization established by Florida Cancer Specialists & Research Institute, LLC (FCS). The acquisition advances community-based oncology care and enables McKesson to continue to accelerate clinical development, improve patient outcomes, and expand access to quality cancer care in local communities. McKesson acquired an approximate 70% controlling intere

      6/3/25 8:00:00 AM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • McKesson Reports Fiscal 2025 Fourth Quarter and Full Year Results and Provides Fiscal 2026 Guidance; Announces Intent to Separate Medical-Surgical Solutions

      McKesson Corporation (NYSE:MCK) has released its fiscal 2025 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Thursday, May 8th at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company's earnings press release, financial tables, and slide presentation. Additional information about upcoming events for the investor community can be found at inves

      5/8/25 4:10:00 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care

    $CAH
    $MCK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by McKesson Corporation (Amendment)

      SC 13G/A - MCKESSON CORP (0000927653) (Subject)

      2/13/24 5:09:38 PM ET
      $MCK
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

      SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

      2/13/24 5:01:02 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • SEC Form SC 13G/A filed by Cardinal Health Inc. (Amendment)

      SC 13G/A - CARDINAL HEALTH INC (0000721371) (Subject)

      1/30/24 1:39:03 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care